These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18503398)

  • 1. Pharmacodynamics of uniform versus nonuniform warfarin dosages.
    Hameed MS; Nafziger AN; Gartung AM; Bertino JS
    Pharmacotherapy; 2008 Jun; 28(6):707-11. PubMed ID: 18503398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy.
    Parra D; Beckey NP; Stevens GR
    Pharmacotherapy; 2007 May; 27(5):675-83. PubMed ID: 17461702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
    Knudsen JF; Sokol GH
    Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose vitamin K to augment anticoagulation control.
    Reese AM; Farnett LE; Lyons RM; Patel B; Morgan L; Bussey HI
    Pharmacotherapy; 2005 Dec; 25(12):1746-51. PubMed ID: 16305294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrice weekly warfarin administration in haemodialysis patients.
    Sood MM; Rigatto C; Bueti J; Lang C; Miller L; PonnamPalam A; Reslerova M; Sood A; Komenda P
    Nephrol Dial Transplant; 2009 Oct; 24(10):3162-7. PubMed ID: 19487735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population.
    Nochowitz B; Shapiro NL; Nutescu EA; Cavallari LH
    Ann Pharmacother; 2009 Jul; 43(7):1165-72. PubMed ID: 19549747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen.
    Siguret V; Gouin I; Debray M; Perret-Guillaume C; Boddaert J; Mahé I; Donval V; Seux ML; Romain-Pilotaz M; Gisselbrecht M; Verny M; Pautas E
    Am J Med; 2005 Feb; 118(2):137-42. PubMed ID: 15694897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparin may alter point-of-care assay for international normalized ratio.
    Phillips EM; Buchan DA; Newman N; Rajan A; Zia S
    Pharmacotherapy; 2005 Oct; 25(10):1341-7. PubMed ID: 16185178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral corticosteroids on chronic warfarin therapy.
    Hazlewood KA; Fugate SE; Harrison DL
    Ann Pharmacother; 2006 Dec; 40(12):2101-6. PubMed ID: 17119104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple doses of sitagliptin, a selective DPP-4 inhibitor, do not meaningfully alter pharmacokinetics and pharmacodynamics of warfarin.
    Wright DH; Herman GA; Maes A; Liu Q; Johnson-Levonas AO; Wagner JA
    J Clin Pharmacol; 2009 Oct; 49(10):1157-67. PubMed ID: 19783710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition.
    Dickerson RN; Garmon WM; Kuhl DA; Minard G; Brown RO
    Pharmacotherapy; 2008 Mar; 28(3):308-13. PubMed ID: 18294110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of concurrent use of warfarin with potentially interacting drugs.
    Wittkowsky AK; Boccuzzi SJ; Wogen J; Wygant G; Patel P; Hauch O
    Pharmacotherapy; 2004 Dec; 24(12):1668-74. PubMed ID: 15585436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
    Garwood CL; Dumo P; Baringhaus SN; Laban KM
    Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does celecoxib potentiate the anticoagulant effect of warfarin? A randomized, double-blind, controlled trial.
    Dentali F; Douketis JD; Woods K; Thabane L; Foster G; Holbrook A; Crowther M
    Ann Pharmacother; 2006; 40(7-8):1241-7. PubMed ID: 16804099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are brand-name and generic warfarin interchangeable? Multiple n-of-1 randomized, crossover trials.
    Pereira JA; Holbrook AM; Dolovich L; Goldsmith C; Thabane L; Douketis JD; Crowther MA; Bates SM; Ginsberg JS
    Ann Pharmacother; 2005; 39(7-8):1188-93. PubMed ID: 15914517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed discharges due to initiation of warfarin in atrial fibrillation: a prospective audit.
    Tan ES; Bonnett TJ; Abdelhafiz AH
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):232-5. PubMed ID: 17996662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cranberry does not affect prothrombin time in male subjects on warfarin.
    Li Z; Seeram NP; Carpenter CL; Thames G; Minutti C; Bowerman S
    J Am Diet Assoc; 2006 Dec; 106(12):2057-61. PubMed ID: 17126638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective evaluation of a possible interaction between warfarin and levofloxacin.
    McCall KL; Scott JC; Anderson HG
    Pharmacotherapy; 2005 Jan; 25(1):67-73. PubMed ID: 15767222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin induction at 5 mg daily is safe with a low risk of anticoagulant overdose: results of an audit of patients with deep vein thrombosis commencing warfarin.
    Harper P; Monahan K; Baker B
    Intern Med J; 2005 Dec; 35(12):717-20. PubMed ID: 16313547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.